Author:
Habert Marie-Odile,de Souza Leonardo Cruz,Lamari Foudil,Daragon Nelle,Desarnaud Serge,Jardel Claude,Dubois Bruno,Sarazin Marie
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference15 articles.
1. Blennow K, Hampel H. CSF markers for incipient Alzheimer’s disease. Lancet Neurol 2003;2(10):605–13.
2. Ashford JW, Shih WJ, Coupal J, Shetty R, Schneider A, Cool C, et al. Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease. J Nucl Med 2000;41(1):57–64.
3. Bradley KM, O’Sullivan VT, Soper ND, Nagy Z, King EM, Smith AD, et al. Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer’s disease. Brain 2002;125(Pt 8):1772–81.
4. Tsolaki M, Sakka V, Gerasimou G, Dimacopoulos N, Chatzizisi O, Fountoulakis KN, et al. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer’s type, other types of dementia, and control subjects. Am J Alzheimers Dis Other Demen 2001;16(1):21–31.
5. Ceravolo R, Borghetti D, Kiferle L, Tognoni G, Giorgetti A, Neglia D, et al. CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer’s disease. Brain Res Bull 2008;76(1–2):80–4.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献